Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.

Overview of attention for article published in Clinical Cancer Research, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 11 news stories from 10 outlets.

(HealthDay News) — In a trial involving patients with therapy-refractory cancer treated with approved targeted or…

New data appear to support expanding eligibility criteria for cancer trials, according to researchers.1 They found that, in a…

Patients with treatment-refractory cancers who did not meet eligibility criteria for a pan-cancer clinical trial but received…

Patients with treatment-refractory cancers who did not meet eligibility criteria for a pan-cancer clinical trial but received…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 7 additional news stories.